HHS cracks down on hidden insurance fees – Pharmaceutical Technology
The US HHS is proposing policy changes to increase transparency surrounding insurance costs. Credit: fizkes via Shutterstock. The US Department of Health and Human Services
The US HHS is proposing policy changes to increase transparency surrounding insurance costs. Credit: fizkes via Shutterstock. The US Department of Health and Human Services
For millennia, natural psychedelics such as magic mushrooms, ayahuasca and mescaline have been used by indigenous peoples in medicinal or spiritual contexts. In the last
Entresto is listed as a key growth driver for Novartis, having yielded $4.64bn in sales in 2022, as per the company’s FY2022 results. Credit: lucarista
While Nanobiotix would maintain operational control over the ongoing clinical studies, including NANORAY-312, Janssen would reserve the right to assume control of these studies. Image
Leqvio is priced at around $6,500 a year, which is comparable to its competitors Sanofi/Regeneron’s Repatha (evolocumab) and Amgen’s Praluent (alirocumab). Image Credit: SurfsUp /
TerrAscend has had a watershed moment, and Canopy Growth reaches $0 price target. Welcome to our latest Trade to Black podcast. Host Shadd Dales, millennial
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so-predictable routine of meetings and
Researchers compared outcomes related to three direct oral anticoagulant (DOAC) care models.
Source: GlobalData, Drugs Database (Accessed: 22 June 2023). According to GlobalData’s Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis –
Researchers estimated patterns of psychological distress.